Results 201 to 207 of about 11,390 (207)

Solid lipid nanoparticles as an efficient drug delivery system of olmesartan medoxomil for the treatment of hypertension

Colloids and Surfaces B: Biointerfaces, 2018
Parva Jani, Jigar D Vanza, Hemal Tandel
exaly  

An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells

British Journal of Pharmacology, 2003
exaly  

Olmesartan medoxomil

Reactions Weekly, 2014
openaire   +2 more sources

Development of olmesartan medoxomil lipid-based nanoparticles and nanosuspension: preparation, characterization and comparative pharmacokinetic evaluation

Artificial Cells, Nanomedicine and Biotechnology, 2018
exaly  

The new oral angiotensin II antagonist olmesartan medoxomil: a concise overview

Journal of Human Hypertension, 2002
exaly  

Molecular characterisation of the interactions between olmesartan and telmisartan and the human angiotensin II AT1 receptor

British Journal of Pharmacology, 2007
exaly  

Olmesartan medoxomil

Reactions Weekly, 2018
openaire   +1 more source